KLP Kapitalforvaltning AS lifted its stake in Envista Holdings Corporation (NYSE:NVST – Free Report) by 11.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 36,400 shares of the company’s stock after buying an additional 3,700 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Envista were worth $711,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of NVST. Alliancebernstein L.P. grew its stake in Envista by 1,985.1% in the 1st quarter. Alliancebernstein L.P. now owns 4,550,789 shares of the company’s stock valued at $78,547,000 after acquiring an additional 4,332,541 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Envista by 24.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company’s stock valued at $144,760,000 after buying an additional 1,625,206 shares during the period. Pzena Investment Management LLC raised its position in Envista by 160.7% in the first quarter. Pzena Investment Management LLC now owns 2,294,257 shares of the company’s stock valued at $39,599,000 after purchasing an additional 1,414,080 shares during the period. Trexquant Investment LP grew its stake in shares of Envista by 243.7% in the first quarter. Trexquant Investment LP now owns 1,065,849 shares of the company’s stock valued at $18,397,000 after buying an additional 755,725 shares in the last quarter. Finally, Gates Capital Management Inc. boosted its holdings in Envista by 10.0% during the 1st quarter. Gates Capital Management Inc. now owns 5,163,745 shares of the company’s stock valued at $89,126,000 after acquiring an additional 469,597 shares during the period.
Envista Stock Up 0.5%
NYSE:NVST opened at $19.70 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.08 and a current ratio of 2.44. The company has a market capitalization of $3.27 billion, a price-to-earnings ratio of 61.56, a price-to-earnings-growth ratio of 1.05 and a beta of 1.01. Envista Holdings Corporation has a one year low of $14.22 and a one year high of $23.00. The stock has a 50-day simple moving average of $20.66 and a 200 day simple moving average of $19.02.
Analysts Set New Price Targets
A number of analysts recently weighed in on the stock. Zacks Research lowered shares of Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 15th. Stifel Nicolaus upped their price objective on Envista from $24.00 to $25.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Evercore ISI set a $25.00 target price on Envista in a research report on Wednesday, October 8th. Wells Fargo & Company lifted their price objective on Envista from $17.00 to $19.00 and gave the stock an “equal weight” rating in a report on Friday, August 1st. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Envista in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Envista presently has an average rating of “Hold” and an average price target of $21.08.
Check Out Our Latest Stock Analysis on Envista
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories
- Five stocks we like better than Envista
- The Basics of Support and Resistance
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- Basic Materials Stocks Investing
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.